Windtree Price To Sales Ratio from 2010 to 2024
| WINT Stock | USD 0.50 0.01 1.96% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 666.48 | Current Value 633.15 | Quarterly Volatility 2.4 K |
Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 77.9 K, Interest Expense of 47.5 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 633, Dividend Yield of 0.0 or PTB Ratio of 0.8. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.
Windtree | Price To Sales Ratio |
Latest Windtree Therapeutics' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Windtree Therapeutics over the last few years. Price to Sales Ratio is figured by comparing Windtree Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Windtree Therapeutics sales, a figure that is much harder to manipulate than other Windtree Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Windtree Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Windtree Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 660.53 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Windtree Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 1,449 | |
| Geometric Mean | 627.44 | |
| Coefficient Of Variation | 164.89 | |
| Mean Deviation | 1,516 | |
| Median | 579.55 | |
| Standard Deviation | 2,389 | |
| Sample Variance | 5.7M | |
| Range | 8.5K | |
| R-Value | (0.45) | |
| Mean Square Error | 4.9M | |
| R-Squared | 0.20 | |
| Significance | 0.09 | |
| Slope | (241.23) | |
| Total Sum of Squares | 79.9M |
Windtree Price To Sales Ratio History
About Windtree Therapeutics Financial Statements
Windtree Therapeutics shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 666.48 | 633.15 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.